President and Chief Executive Officer
Malcolm is a serial entrepreneur and has been CEO of several venture backed equipment and expendables companies over his long career. He has worked in the medical diagnostic, analytical instrument, membrane filtration and water treatment and purification industries. Mr. Kahn earned his BA at the Pennsylvania State University and MBA at Fordham.
Mark Meyerhoff, Ph.D.
Chief Technology Officer
As the NOTA Laboratories lead co-founder, Dr. Meyerhoff has set the vision and direction for the company. Having suffered from chronic sinusitis himself, Dr. Meyerhoff is now leveraging his prior and current research at the University of Michigan to develop a novel solution to CRS. Dr. Meyerhoff’s research laboratory has been active in the field of nitric oxide release materials and their characterization, with emphasis on novel NO-releasing polymers and solutions for potential application in medicine. Dr. Meyerhoff has been working in the field nitric oxide research for >20 years.
Dr. Mark Meyerhoff is also the Philip J. Erving Professor of Chemistry at the University of Michigan Department of Chemistry, joining the university in the fall of 1979 as an Assistant Professor, and serving as a full professor since 1990. Dr. Meyerhoff sits on Scientific Advisory Boards for a number of biomedical companies. He received his Ph.D. from the State University of New York at Buffalo in 1979.
Chief Medical Officer
Dr. Drake is a practicing cardiac and thoracic surgeon with over 20 years of experience. He is passionate about nitric oxide's therapeutic applications and collaborates with Dr. Robert Bartlett's University of Michigan research laboratory to apply nitric oxide in cardiac surgery research. Dr. Drake received his M.D. from the University of Michigan in 1982.
Glenn Martin, Ph.D.
Director of R&D
Dr. Martin received his BS in Chemistry in 1985 and PhD in 1993. Dr. Martin founded Selective Technology Inc. in 1993, Analytical Chemist/Chemistry Manager at Sensicore, Inc. 2003-2008, Staff Scientist/Principal Research Scientist at Abbott Laboratories 2008-2018 and joined NOTA Labs in 2018 as Director of R&D.
Chief Financial Officer
As a 2014 co-founder, Paul brings over a decade of cross-functional industry experience to NOTA Laboratories, spanning from corporate finance and accounting to medical device R&D project management, healthcare economics, and product marketing. Mr. Rabinovich earned his B.A. at Brandeis University, and his MBA from the University of Michigan.
Joan Keiser, Ph.D.
Dr. Keiser leads regulatory affairs at NOTA Laboratories. She spent ten years working as Vice President of Research at Pfizer. She brings a breadth of experience and network to NOTA Laboratories. Prior to joining NOTA, Dr. Keiser spent seven years as Managing Director of the University of Michigan North Campus Research Complex.
Uma Sajjan, Ph.D.
Dr. Sajjan is a co-founder and member of the NOTA Laboratories Scientific Advisory Board. She is Associate Professor of Physiology at Temple University. Dr. Sajjan's brings extensive experience in development and execution of in vitro and in vivo models for antimicrobial and antiviral agents, and has researched extensively lower respiratory disease states and inflammatory responses.
MEDICAL ADVISORY BOARD
Mark Zacharek, M.D.
Director of the Michigan Sinus Center
University of Michigan Professor, Otolaryngology
Marc Hershenson, M.D.
University of Michigan Professor, Pediatrics-Pulmonary Medicine
Chuanwu Xi, Ph.D.
University of Michigan Professor, Environmental Health Sciences and Global Public Health
Robert Bartlett, M.D.
University of Michigan Professor Emeritus, General Surgery
Raimon Duran-Struuck, DVM, Ph.D.
University of Pennsylvania Associate Director, Regulatory Support and Scientist Training
University of Pennsylvania Director, Laboratory Animal Medicine Residency Program
David Brownstein, M.D.
Medical Director, Center for Holistic Medicine, Bloomfield, Michigan